Advertisement
Advertisement

A

A logo

Agilent Technologies Inc.

129.67
USD
Sponsored
+0.03
+0.02%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

130.23

+0.56
+0.43%

A Earnings Reports

Positive Surprise Ratio

A beat 32 of 39 last estimates.

82%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.84B
/
$1.39
Implied change from Q4 25 (Revenue/ EPS)
-1.01%
/
-12.58%
Implied change from Q1 25 (Revenue/ EPS)
+9.59%
/
+6.11%

Agilent Technologies Inc. earnings per share and revenue

On Nov 24, 2025, A reported earnings of 1.59 USD per share (EPS) for Q4 25, missing the estimate of 1.61 USD, resulting in a -1.60% surprise. Revenue reached 1.86 billion, compared to an expected 1.87 billion, with a -0.42% difference. The market reacted with a +2.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 18 analysts forecast an EPS of 1.39 USD, with revenue projected to reach 1.84 billion USD, implying an decrease of -12.58% EPS, and decrease of -1.01% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
logo
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
logo
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
logo
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
logo
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
logo
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
logo
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
logo
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
logo
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
FAQ
For Q4 2025, Agilent Technologies Inc. reported EPS of $1.59, missing estimates by -1.6%, and revenue of $1.86B, -0.42% below expectations.
The stock price moved up 2.34%, changed from $153.60 before the earnings release to $157.20 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 18 analysts, Agilent Technologies Inc. is expected to report EPS of $1.39 and revenue of $1.84B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement